摘要
建立补体介导的脂质体免疫裂解试验(LILA)以检验人血清中胰岛素含量。应用逆相蒸发法(REV)制备包裹有丽丝胺罗丹明B的大单层脂质体(LUVs),通过碳二亚胺(EDCI)法偶联胰岛素抗原,当加入胰岛素抗原、一定量抗体,在补体参与下,建立竞争抑制测定模式。结果,丽丝胺罗丹明B吸光度值的改变与血清中胰岛素浓度呈线性关系,回归方程为,Y=227.72-80.441X(r=-0.9966),批内变异系数(CV)为3.8%~8.5%,批间CV9.3%~13.0%,回收率为83.4%~114.0%,灵敏度为1.25μU/ml,LILA(Y)和RIA(X)相关显著,Y=1.03X+0.43(r=0.977,P<0.001)。
To develope complement mediated liposome immunolysis assay(LILA)for detecting insulin concentration in human serum.Reverse phase evaporation (REV)method to prepare large unilamellar vesicles(LUVs)encapsulated sulforhodamine B,and obtained immunoliposome by using 1 ethy1 3(3 dimethylaminopropy1)carbodiimide(EDCI)which made insulin couple the LUVs.Competing inhibition assay could be achieved upon the addition of free insulin and anti insulin antibody in the presence of complement.The results revealed that there was a excellent negative correlation between the absorption change of sulforhodamine B and insulin concentration in serum( r =-0 9966). The within run CV and between run CV were 3 8% ̄8 5%( n =12),9 3% ̄13 0%( n =6)respectively.The recovery was 83 4% ̄114 0%.the sensitivity was 1 25 μU/ml. The correlation between LILA( Y ) and RIA (X )was significant: Y=1 03X+0 43(r=0 977,P <0 001).LILA is simple, rapid, specific,sensitive and stable method which is worthy to be studied and popularized.
出处
《临床检验杂志》
CAS
CSCD
北大核心
1999年第1期19-21,共3页
Chinese Journal of Clinical Laboratory Science